Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Following administration in phase 1 and phase 2 clinical studies[16]: Time to maximum concentration (Tmax) occurs 12 to 72 hours after subcutaneous injection Dose-proportional pharmacokinetics observed across the therapeutic dose range (1 mg to 12 mg) Steady-state concentrations achieved after approximately 4 weeks of weekly dosing The fatty diacid conjugation enables albumin binding, extending circulation time Systemic exposure increases proportionally with dose escalation Distribution studies indicate widespread tissue distribution following absorption, with concentrations sufficient to engage receptor systems in metabolically relevant tissues including adipose tissue, liver, pancreas, and central nervous system regions involved in appetite regulation
The epidemiology of thyroid disease
Selection preferences for concomitant oral antidiabetic drugs were also analyzed, and their distribution across the second- to fourth-choice therapies is illustrated in Figure 3B
It has taken the place of OZEMPIC globally a famous semaglutide by NovoNordisk
US$ 20.08
US$ 24.67
US$ 24.92
